Oxervate opothalmic solution medication

Ended Awarded

Contract number
36C24122N0067
Awardee
Awarding agency
Obligated
$70,914

Award facts

Contract value 100% obligated
$70,914.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bartlett, TN 38134, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Department of Veterans Affairs, through the Veterans Integrated Service Network 1, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, to provide Oxervate ophthalmic solution medication. The contract, valued at $70,914.40, is funded through the VA's pharmaceutical and drugs acquisition schedule (FSS-61-IB). Dompe U.S. Inc. has provided Oxervate and other pharmaceutical products to the VA through various contract vehicles to meet the urgent medication needs of veterans. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 36C24122N0067?

36C24122N0067 was awarded to Dompe U.s. Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on October 5, 2021.

How much is contract 36C24122N0067 worth?

The government has obligated $70,914 on 36C24122N0067.

Is contract 36C24122N0067 an order under another contract?

Yes. 36C24122N0067 is a BPA call under 36F79720D0017-36E79720A0004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24122N0067 competed?

The extent of competition for 36C24122N0067 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award